McClain KL - Search Results

1

International expert consensus recommendations for the diagnosis and treatment of Langerhans cell histiocytosis in adults.

Goyal G, Tazi A, Go RS, Rech KL, Picarsic JL, Vassallo R, Young JR, Cox CW, Van Laar J, Hermiston ML, Cao XX, Makras P, Kaltsas G, Haroche J, Collin M, McClain KL, Diamond EL, Girschikofsky M. Goyal G, et al. Among authors: mcclain kl. Blood. 2022 Apr 28;139(17):2601-2621. doi: 10.1182/blood.2021014343. Blood. 2022. PMID: 35271698 Free PMC article.

2

Langerhans cell histiocytosis: lack of a viral etiology.

McClain K, Jin H, Gresik V, Favara B. McClain K, et al. Am J Hematol. 1994 Sep;47(1):16-20. doi: 10.1002/ajh.2830470104. Am J Hematol. 1994. PMID: 8042610

3

Viruses and Langerhans cell histiocytosis: is there a link?

McClain K, Weiss RA. McClain K, et al. Br J Cancer Suppl. 1994 Sep;23:S34-6. Br J Cancer Suppl. 1994. PMID: 8075003 Free PMC article. Review.

4

DNA polymorphisms and mutations of the tumor necrosis factor-alpha (TNF-alpha) promoter in Langerhans cell histiocytosis (LCH).

Wu WS, McClain KL. Wu WS, et al. Among authors: mcclain kl. J Interferon Cytokine Res. 1997 Oct;17(10):631-5. doi: 10.1089/jir.1997.17.631. J Interferon Cytokine Res. 1997. PMID: 9355965 Clinical Trial.

5

Need for a cooperative study: Pulmonary Langerhans cell histiocytosis and its management in adults.

McClain KL, Gonzalez JM, Jonkers R, De Juli E, Egeler M. McClain KL, et al. Med Pediatr Oncol. 2002 Jul;39(1):35-9. doi: 10.1002/mpo.10064. Med Pediatr Oncol. 2002. PMID: 12116077 Review.

6

Adult Langerhans cell histiocytosis limited to the skin.

Singh A, Prieto VG, Czelusta A, McClain KL, Duvic M. Singh A, et al. Among authors: mcclain kl. Dermatology. 2003;207(2):157-61. doi: 10.1159/000071786. Dermatology. 2003. PMID: 12920365 Review.

7

Langerhans cell histiocytosis in adults. Report from the International Registry of the Histiocyte Society.

Aricò M, Girschikofsky M, Généreau T, Klersy C, McClain K, Grois N, Emile JF, Lukina E, De Juli E, Danesino C. Aricò M, et al. Eur J Cancer. 2003 Nov;39(16):2341-8. doi: 10.1016/s0959-8049(03)00672-5. Eur J Cancer. 2003. PMID: 14556926

8

Permanent consequences in Langerhans cell histiocytosis patients: a pilot study from the Histiocyte Society-Late Effects Study Group.

Haupt R, Nanduri V, Calevo MG, Bernstrand C, Braier JL, Broadbent V, Rey G, McClain KL, Janka-Schaub G, Egeler RM. Haupt R, et al. Among authors: mcclain kl. Pediatr Blood Cancer. 2004 May;42(5):438-44. doi: 10.1002/pbc.20021. Pediatr Blood Cancer. 2004. PMID: 15049016

9

Efficacy of continuous infusion 2-CDA (cladribine) in pediatric patients with Langerhans cell histiocytosis.

Stine KC, Saylors RL, Saccente S, McClain KL, Becton DL. Stine KC, et al. Among authors: mcclain kl. Pediatr Blood Cancer. 2004 Jul;43(1):81-4. doi: 10.1002/pbc.20053. Pediatr Blood Cancer. 2004. PMID: 15170896 Clinical Trial.

10

Anti-CD52 antibody, alemtuzumab, binds to Langerhans cells in Langerhans cell histiocytosis.

Jordan MB, McClain KL, Yan X, Hicks J, Jaffe R. Jordan MB, et al. Among authors: mcclain kl. Pediatr Blood Cancer. 2005 Mar;44(3):251-4. doi: 10.1002/pbc.20181. Pediatr Blood Cancer. 2005. PMID: 15390358

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

212 results

Search Page

Filters